Drug Therapy, Combination
"Drug Therapy, Combination" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Therapy with two or more separate preparations given for a combined effect.
Concept/Terms
Drug Therapy, Combination- Drug Therapy, Combination
- Combination Chemotherapy
- Drug Polytherapy
- Drug Polytherapies
- Polytherapies, Drug
- Polytherapy, Drug
- Therapy, Combination Drug
- Chemotherapy, Combination
- Chemotherapies, Combination
- Combination Chemotherapies
- Combination Drug Therapy
- Combination Drug Therapies
- Drug Therapies, Combination
- Therapies, Combination Drug
Below are MeSH descriptors whose meaning is more general than "Drug Therapy, Combination".
Below are MeSH descriptors whose meaning is more specific than "Drug Therapy, Combination".
This graph shows the total number of publications written about "Drug Therapy, Combination" by people in Harvard Catalyst Profiles by year, and whether "Drug Therapy, Combination" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 5 | 44 | 49 |
1995 | 4 | 46 | 50 |
1996 | 4 | 64 | 68 |
1997 | 1 | 56 | 57 |
1998 | 1 | 90 | 91 |
1999 | 4 | 89 | 93 |
2000 | 2 | 102 | 104 |
2001 | 1 | 87 | 88 |
2002 | 0 | 107 | 107 |
2003 | 2 | 118 | 120 |
2004 | 3 | 144 | 147 |
2005 | 4 | 127 | 131 |
2006 | 3 | 140 | 143 |
2007 | 1 | 150 | 151 |
2008 | 0 | 173 | 173 |
2009 | 1 | 175 | 176 |
2010 | 2 | 162 | 164 |
2011 | 2 | 141 | 143 |
2012 | 7 | 147 | 154 |
2013 | 4 | 164 | 168 |
2014 | 1 | 119 | 120 |
2015 | 3 | 169 | 172 |
2016 | 4 | 185 | 189 |
2017 | 4 | 193 | 197 |
2018 | 3 | 158 | 161 |
2019 | 2 | 176 | 178 |
2020 | 2 | 135 | 137 |
2021 | 2 | 101 | 103 |
2022 | 0 | 54 | 54 |
2023 | 0 | 43 | 43 |
2024 | 0 | 4 | 4 |
Below are the most recent publications written about "Drug Therapy, Combination" by people in Profiles.
-
Induction of durable remission by dual immunotherapy in SHIV-infected ART-suppressed macaques. Science. 2024 Mar 08; 383(6687):1104-1111.
-
Combination pharmacological therapy targeting multiple mechanisms of sleep apnoea: a randomised controlled cross-over trial. Thorax. 2024 Feb 15; 79(3):259-268.
-
1- Versus 3-Month DAPT in Older Patients at a High Bleeding Risk Undergoing PCI: Insights from the XIENCE Short DAPT Global Program. Am J Cardiol. 2024 Mar 01; 214:94-104.
-
Duration of Dual Antiplatelet Treatment After Percutaneous Coronary Intervention in Patients With Diabetes: A Systematic Review and Meta-analysis. J Cardiovasc Pharmacol. 2024 Jan 01; 83(1):64-72.
-
The Cost-Effectiveness of Rivaroxaban Plus Aspirin Compared with Aspirin Alone in the COMPASS Trial: A US Perspective. Am J Cardiovasc Drugs. 2024 Jan; 24(1):117-127.
-
The effect of smoking on response to methotrexate in rheumatoid arthritis patients: A systematic review and meta-analysis. Mod Rheumatol. 2023 Dec 22; 34(1):68-78.
-
Ultralow-dose quadruple combination therapy: a cost-effective solution for hypertension control. Heart. 2023 10 26; 109(22):1659-1660.
-
Effectiveness of spironolactone for women with acne vulgaris (SAFA) trial: a critically appraised topic. Br J Dermatol. 2023 10 25; 189(5):509-510.
-
Rivaroxaban Plus Aspirin Versus Aspirin Alone After Endovascular Revascularization for Symptomatic PAD: Insights From VOYAGER PAD. Circulation. 2023 Dec 12; 148(24):1919-1928.
-
1- or 3-Month DAPT in Patients With HBR With or Without Oral Anticoagulant Therapy After PCI. JACC Cardiovasc Interv. 2023 10 23; 16(20):2498-2510.